Latest Breaking News On - Cymabay initiates - Page 1 : comparemela.com

Results from RESPONSE show seladelpar may improve measures of disease activity and reduce symptom burden in patients with PBC.

Gideon hirschfieldTerry hornerDrug administrationRegulatory agencyFoundation gideon hirschfieldEuropean medicines agencyToronto centre for liver diseaseAutoimmune liver disease researchBay therapeuticsTerry horner chairToronto centreSeladelpar achieves high statistical significanceKey secondary endpointsPrimary biliaryCymabay initiatesRandomized study